Overall, our pan-cancer analyses of XCR1 have elaborated the landscape of XCR1 expression with the clinical prognosis and immune cell infiltration, which provide a predictive biomarker in pan-cancer, especially in LIHC, KIRC, LUAD, HNSC, and COAD. The gene discussed is XCR1; the disease is colon adenocarcinoma.